Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of US$ 280/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Luliconazole |
CAS | 187164-19-8 |
Appearance | White Powder |
Molecular Formula | C14H9Cl2N3S2 |
Assay | >99% |
Storage | Store in a well-closed,light-resistant container |
Luliconazole is a new type of imidazole topical antifungal drug, which is an analog of lanoconazole. It interferes with fungal cell wall synthesis and fungal growth by inhibiting the activity of lanosterol demethylase and reducing the level of ergosterol. In addition to being used in the treatment of tinea pedis, jock itch and tinea corporis, it has also been developed for the treatment of onychomycosis (onychomycosis).
Dermal Antifungal Treatment: Luliconazole is primarily used topically for the treatment of superficial skin infections caused by fungi, such as tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm).
Anti-inflammatory Effect: Although its primary function is antifungal, luliconazole may also exhibit some anti-inflammatory properties, aiding in reducing irritation and inflammation associated with fungal infections.
Preventative Measure: In some cases, it can be applied prophylactically to prevent recurrence of fungal infections in individuals prone to such conditions, especially in areas prone to moisture and friction.
Broad-Spectrum Antifungal Activity: Luliconazole functions by inhibiting ergosterol biosynthesis, a crucial component of fungal cell membranes. This disrupts membrane integrity and leads to fungal cell death, effectively treating a wide range of dermatophyte fungi.
Rapid Onset of Action: It exhibits a rapid onset of antifungal activity, allowing for faster relief of symptoms associated with fungal skin infections.
Long-Lasting Efficacy: Due to its unique chemical structure, luliconazole provides a prolonged antifungal effect, reducing the need for frequent reapplication and enhancing patient compliance.